.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
Cerilliant
Cipla
Chubb
Covington
Express Scripts
Accenture
Dow
QuintilesIMS

Generated: September 24, 2017

DrugPatentWatch Database Preview

Fluorouracil - Generic Drug Details

« Back to Dashboard

What are the generic sources for fluorouracil and what is the scope of fluorouracil patent protection?

Fluorouracil
is the generic ingredient in six branded drugs marketed by Bedford, Sagent Pharms, Spectrum Pharms, Abraxis Pharm, Mylan Pharms Inc, Pharmacia And Upjohn, Teva Parenteral, Spear Pharms, Taro Pharm, Abic, Valeant Pharm Intl, Teva Pharms Usa, Smith And Nephew, Accord Hlthcare, Hill Dermaceuticals, Elorac, Taro, Mylan Labs Ltd, Ebewe Pharma, Fresenius Kabi Usa, Valeant Pharms North, Aqua Pharms, Marchar, and Sandoz, and is included in thirty-eight NDAs. There are two patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Fluorouracil has three patent family members in three countries.

There are fifteen drug master file entries for fluorouracil. Twenty suppliers are listed for this compound.

Summary for Generic Name: fluorouracil

Tradenames:6
Patents:2
Applicants:24
NDAs:38
Drug Master File Entries: see list15
Suppliers / Packagers: see list20
Bulk Api Vendors: see list124
Clinical Trials: see list1,344
Patent Applications: see list179
Therapeutic Class:Dermatological Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:fluorouracil at DailyMed

Pharmacology for Ingredient: fluorouracil

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Labs Ltd
FLUOROURACIL
fluorouracil
INJECTABLE;INJECTION202668-001Jul 17, 2012APRXNoNo► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
ADRUCIL
fluorouracil
INJECTABLE;INJECTION081222-001Jun 28, 1991DISCNNoNo► Subscribe► Subscribe► Subscribe
Elorac
FLUOROPLEX
fluorouracil
SOLUTION;TOPICAL016765-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Fresenius Kabi Usa
FLUOROURACIL
fluorouracil
INJECTABLE;INJECTION040379-001Nov 15, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe
Smith And Nephew
FLUOROURACIL
fluorouracil
INJECTABLE;INJECTION088767-001Dec 28, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Taro
FLUOROURACIL
fluorouracil
CREAM;TOPICAL090368-001Mar 5, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Abraxis Pharm
FLUOROURACIL
fluorouracil
INJECTABLE;INJECTION089519-001Mar 12, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Accord Hlthcare
FLUOROURACIL
fluorouracil
INJECTABLE;INJECTION040798-001Apr 26, 2007APRXNoYes► Subscribe► Subscribe► Subscribe
Spectrum Pharms
FLUOROURACIL
fluorouracil
INJECTABLE;INJECTION087792-001Oct 13, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Valeant Pharm Intl
EFUDEX
fluorouracil
CREAM;TOPICAL016831-003Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: fluorouracil

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant Pharms North
CARAC
fluorouracil
CREAM;TOPICAL020985-001Oct 27, 2000► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: fluorouracil

Country Document Number Estimated Expiration
European Patent Office1696868► Subscribe
Canada2541373► Subscribe
World Intellectual Property Organization (WIPO)2005009406► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Citi
Argus Health
Baxter
Colorcon
Accenture
Express Scripts
Cipla
Julphar
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot